Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,589
Closed -$342K 1446
2025
Q4
$342K Buy
4,589
+341
+8% +$24.9K 0.01% 1059
2025
Q3
$287K Buy
4,248
+518
+14% +$34.4K 0.01% 1057
2025
Q2
$243K Buy
3,730
+278
+8% +$16.7K 0.01% 1039
2025
Q1
$213K Buy
3,452
+24
+0.7% +$1.59K 0.01% 1000
2024
Q4
$247K Sell
3,428
-2,460
-42% -$192K 0.01% 929
2024
Q3
$480K Sell
5,888
-585
-9% -$46.8K 0.02% 593
2024
Q2
$481K Buy
6,473
+55
+0.9% +$4.12K 0.02% 576
2024
Q1
$500K Sell
6,418
-1,731
-21% -$129K 0.03% 517
2023
Q4
$582K Buy
8,149
+206
+3% +$14.3K 0.03% 467
2023
Q3
$551K Buy
7,943
+1,642
+26% +$124K 0.04% 401
2023
Q2
$510K Buy
+6,301
New +$515K 0.05% 412
2019
Q1
Sell
-146
Closed -$6K 939
2018
Q4
$6K Buy
+146
New +$5.99K ﹤0.01% 1314
2018
Q1
$5K Hold
147
﹤0.01% 1303
2017
Q4
$6K Buy
+147
New +$5.86K ﹤0.01% 1239

Other funds holding HOLX

MGO One Seven's HOLX Position: Q1 2026 in Review

MGO One Seven sold out of Hologic (HOLX) in Q1 2026, closing a stake of 4,589 shares — an estimated $342K sold.

MGO One Seven first reported a position in HOLX in Q4 2017 and held it in 14 quarters. The position peaked at $582K in Q4 2023. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.

  • MGO One Seven reported no remaining Hologic position as of Q1 2026 after selling out during the quarter.
  • MGO One Seven sold 4,589 Hologic shares in Q1 2026, an estimated $342K.
  • MGO One Seven first reported a position in Hologic in Q4 2017 and held it in 14 quarters.
  • MGO One Seven's Hologic position peaked at $582K in Q4 2023.
  • 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.

Based on MGO One Seven's 13F filing for Q1 2026, filed 14 May 2026.